Cardiac sarcoidosis responding to monotherapy with infliximab

被引:0
|
作者
Imad Uthman
Zahi Touma
Maurice Khoury
机构
[1] American University of Beirut Medical Center,Department of Internal Medicine, Faculty of Medicine
来源
Clinical Rheumatology | 2007年 / 26卷
关键词
Heart block; Infliximab; Sarcoidosis; Tumor necrosis factor;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiac involvement is a rare and potentially life-threatening complication of sarcoidosis. We report the case of a young previously healthy woman who presented with complete atrioventricular heart block. Further evaluation revealed non-caseating granulomas in the hilar and mediastinal regions. A pacemaker was inserted, and she was treated with four doses of infliximab after she refused treatment with steroids. Rapid resolution of the pulmonary lymph nodes was documented and repeated interrogations of the pacemaker 1 year after her last infliximab infusion documented that she was in sinus rhythm. Infliximab may be considered as an alternative first-line therapy in sarcoidosis with serious organ involvement.
引用
收藏
页码:2001 / 2003
页数:2
相关论文
共 50 条
  • [41] Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
    Judson, M. A.
    Baughman, R. P.
    Costabel, U.
    Flavin, S.
    Lo, K. H.
    Kavuru, M. S.
    Drent, M.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1189 - 1196
  • [42] Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab
    Boris A. Cruz
    Dorothy D. Reis
    Célia Aparecida A. Araujo
    Rheumatology International, 2007, 27 : 1181 - 1183
  • [43] THE ROLE OF INFLIXIMAB IN TREATING REFRACTORY CARDIAC SARCOIDOSIS. CASE SERIES AND SYSTEMATIC REVIEW OF LITERATURE
    Ahmed, Raheel
    Okafor, Joseph
    Khattar, Rajdeep
    Azzu, Alessia
    Baksi, John
    Wechalekar, Kshama
    Sharma, Rakesh
    Wells, Athol
    Kouranos, Vasilis
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (02)
  • [44] Diagnosis and Management of Cardiac Sarcoidosis
    Dubrey, Simon W.
    Falk, Rodney H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2010, 52 (04) : 336 - 346
  • [45] Management of skin sarcoidosis with minocycline monotherapy
    Sasaki, Shinichi
    Kato, Motoyasu
    Nakamura, Kota
    Namba, Yukiko
    Nagashima, Osamu
    Takahashi, Kazuhisa
    RESPIROLOGY CASE REPORTS, 2019, 7 (04):
  • [46] A double-blinded, randomized, placebo-controlled trial of infliximab in subects with active pulmonary sarcoidosis
    Rossman, Milton D.
    Newman, Lee S.
    Baughman, Robert P.
    Teirstein, Alvin
    Weinberger, Steven E.
    Miller, Wallace, Jr.
    Sands, Bruce E.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2006, 23 (03) : 201 - 208
  • [47] Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
    Abdullah Sakkat
    Gerard Cox
    Nader Khalidi
    Maggie Larche
    Karen Beattie
    Elisabetta A. Renzoni
    Nilesh Morar
    Vasilis Kouranos
    Martin Kolb
    Nathan Hambly
    Respiratory Research, 23
  • [48] Infliximab monotherapy for refractory psoriasis: preliminary results
    Cassano, N
    Loconsole, F
    Amoruso, A
    Coviello, C
    Filieri, M
    Filotico, R
    Del Vecchio, S
    Vena, GA
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2004, 17 (03) : 373 - 380
  • [49] Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab
    Hoitsma, Elske
    Faber, Carin G.
    van Santen-Hoeufft, Marijke
    De Vries, Lolanda
    Reulen, Jos P. H.
    Drent, Marjolein
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2006, 23 (01) : 73 - 77
  • [50] Systemic pyoderma gangrenosum responding to infliximab and adalimumab
    Hubbard, VG
    Friedmann, AC
    Goldsmith, P
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (05) : 1059 - 1061